A study conducted on patients with nonalcoholic fatty liver disease (NAFLD) similarly reported that the consumption of synbiotic yoghurt did not lead to significant differences in serum AST and ALT levels. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.